Genetic and Morphological Features of Human iPSC-Derived Neurons with Chromosome 15q11.2 (BP1-BP2) Deletions

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecular Neuropsychiatry

• Publication date

  2015-06-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000430916PMID 26528485PMCID PMC4627696
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review

  2015cited by this paper
• MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine–Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective

  2014cited by this paper
• Persistent Infection by HSV-1 Is Associated With Changes in Functional Architecture of iPSC-Derived Neurons and Brain Activation Patterns Underlying Working Memory Performance

  2014cited by this paper
• Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity.

  2014cited by this paper
• Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR

  2014cited by this paper
• iPS cells: a game changer for future medicine

  2014cited by this paper
• Phenotypic features in patients with 15q11.2(BP1‐BP2) deletion: Further delineation of an emerging syndrome

  2014cited by this paper
• The autism and schizophrenia associated gene CYFIP1 is critical for the maintenance of dendritic complexity and the stabilization of mature spines

  2014cited by this paper
• Structural dynamics of dendritic spines: molecular composition, geometry and functional regulation.

  2014cited by this paper
• Dendritic spine pathology in schizophrenia.

  2013cited by this paper
• CNVs conferring risk of autism or schizophrenia affect cognition in controls

  2013cited by this paper
• Comparative neuronal differentiation of self-renewing neural progenitor cell lines obtained from human induced pluripotent stem cells

  2013cited by this paper
• Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells

  2012cited by this paper
• Increased expression of Kalirin-9 in the auditory cortex of schizophrenia subjects: its role in dendritic pathology.

  2012cited by this paper
• Human Induced Pluripotent Stem Cell-Derived Models to Investigate Human Cytomegalovirus Infection in Neural Cells

  2012cited by this paper
• A Copy Number Variation Morbidity Map of Developmental Delay

  2011cited by this paper
• Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay

  2011cited by this paper
• LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress.

  2011cited by this paper
• Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors

  2011cited by this paper
• Dendritic spine pathology in neuropsychiatric disorders

  2011cited by this paper
• Excitation-induced ataxin-3 aggregation in neurons from patients with Machado–Joseph disease

  2011cited by this paper
• Modelling schizophrenia using human induced pluripotent stem cells

  2011cited by this paper
• Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies.

  2010cited by this paper
• Nine patients with a microdeletion 15q11.2 between breakpoints 1 and 2 of the Prader-Willi critical region, possibly associated with behavioural disturbances.

  2009cited by this paper
• Efficient reprogramming of human and mouse primary extra‐embryonic cells to pluripotent stem cells

  2009cited by this paper
• A co‐segregating microduplication of chromosome 15q11.2 pinpoints two risk genes for autism spectrum disorder

  2009cited by this paper
• A network of dopaminergic gene variations implicated as risk factors for schizophrenia.

  2008cited by this paper
• Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation.

  2008cited by this paper
• Human IL-12 p40 as a reporter gene for high-throughput screening of engineered mouse embryonic stem cells

  2008cited by this paper
• The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP.

  2008cited by this paper
• Large recurrent microdeletions associated with schizophrenia

  2008cited by this paper
• NIPA1(SPG6), the Basis for Autosomal Dominant Form of Hereditary Spastic Paraplegia, Encodes a Functional Mg2+ Transporter*

  2007cited by this paper
• Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment

  2007cited by this paper
• Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons.

  2003cited by this paper
• NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6).

  2003cited by this paper
• Telomere measurement by quantitative PCR.

  2002cited by this paper
• GCP5 and GCP6: two new members of the human gamma-tubulin complex.

  2001cited by this paper
• Autism or atypical autism in maternally but not paternally derived proximal 15q duplication.

  1997cited by this paper

• Altered Neuronal Architecture in Induced Pluripotent Stem Cells-Derived Neurons from Patients with Schizophrenia Harboring CNTNAP2 Deletion

  2026cites this paper
• Beyond the Copy Number Differences: The Phenotypic Diversity of Children With 15q11.2 Microdeletions and Microduplications

  2025cites this paper
• Review of structural neuroimaging and genetic findings in autism spectrum disorder – a clinical perspective

  2024cites this paper
• Behavioral and Psychiatric Disorders in Syndromic Autism

  2024cites this paper
• Human stem cell-based models to study synaptic dysfunction and cognition in schizophrenia: A narrative review.

  2023cites this paper
• Recommendations, guidelines, and best practice for the use of human induced pluripotent stem cells for neuropharmacological studies of neuropsychiatric disorders

  2023cites this paper
• Human-Induced Pluripotent Stem Cells are a Unique Approach for Modeling Schizophrenia: Calcium Homeostasis

  2022cites this paper
• Current advancements of modelling schizophrenia using patient-derived induced pluripotent stem cells

  2022cites this paper
• Passage number affects differentiation of sensory neurons from human induced pluripotent stem cells

  2022cites this paper
• Modeling schizophrenia with iPS cell technology and disease mouse models.

  2021cites this paper
• Induced pluripotent stem cells for 2D and 3D modelling the biological basis of schizophrenia and screening possible therapeutics.

  2021cites this paper
• Aralar Sequesters GABA into Hyperactive Mitochondria, Causing Social Behavior Deficits.

  2020cites this paper
• Treatment-resistant psychotic symptoms and the 15q11.2 BP1–BP2 (Burnside-Butler) deletion syndrome: case report and review of the literature

  2020cites this paper
• A Link between Genetic Disorders and Cellular Impairment, Using Human Induced Pluripotent Stem Cells to Reveal the Functional Consequences of Copy Number Variations in the Central Nervous System—A Close Look at Chromosome 15

  2020cites this paper
• FMRP and CYFIP1 at the Synapse and Their Role in Psychiatric Vulnerability

  2020cites this paper
• Mental health dished up—the use of iPSC models in neuropsychiatric research

  2020cites this paper
• The 15q11.2 BP1-BP2 Microdeletion (Burnside–Butler) Syndrome: In Silico Analyses of the Four Coding Genes Reveal Functional Associations with Neurodevelopmental Disorders

  2020cites this paper
• Dysregulation of protein synthesis and dendritic spine morphogenesis in ASD: studies in human pluripotent stem cells

  2020cites this paper
• Copy number variants (CNVs): a powerful tool for iPSC-based modelling of ASD

  2020cites this paper
• The sociability spectrum: evidence from reciprocal genetic copy number variations

  2020cites this paper
• Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques

  2020cites this paper
• Stem cell models of schizophrenia, what have we learned and what is the potential?

  2019cites this paper
• Contribution of induced pluripotent stem cell technologies to the understanding of cellular phenotypes in schizophrenia.

  2019cites this paper
• From Schizophrenia Genetics to Disease Biology: Harnessing New Concepts and Technologies

  2019cites this paper
• Prenatal diagnosis of a familial 15q11.2 (BP1-BP2) microdeletion encompassing TUBGCP5, CYFIP1, NIPA2 and NIPA1 in a fetus with ventriculomegaly, microcephaly and intrauterine growth restriction on prenatal ultrasound.

  2018cites this paper
• Using Human Induced Neural Precursor Cells to Define Early Neurodevelopmental Defects in Syndromic and Idiopathic Autism

  2018cites this paper
• Childhood-Onset Schizophrenia: Insights from Induced Pluripotent Stem Cells

  2018cites this paper
• Associations between period 3 gene polymorphisms and sleep- /chronotype-related variables in patients with late-life insomnia

  2017cites this paper
• Application value of chromosomal microarray analysis in prenatal diagnosis of lateral ventriculomegaly fetuses

  2017cites this paper
• Familial transmission of recurrent 15q11.2 (BP1-BP2) microdeletion encompassing NIPA1, NIPA2, CYFIP1, and TUBGCP5 associated with phenotypic variability in developmental, speech, and motor delay.

  2017cites this paper
• Cellular models to study schizophrenia: A systematic review.

  2017cites this paper
• Low-Density Neuronal Cultures from Human Induced Pluripotent Stem Cells

  2017cites this paper
• Clinical and genetic aspects of the 15q11.2 BP1–BP2 microdeletion disorder

  2017cites this paper
• Disease modelling using human iPSCs.

  2016cites this paper
• Reduced CYFIP1 in Human Neural Progenitors Results in Dysregulation of Schizophrenia and Epilepsy Gene Networks

  2016cites this paper
• Using Induced Pluripotent Stem Cells to Investigate Complex Genetic Psychiatric Disorders

  2016cites this paper
• Recurrent 15q11.2 BP1‐BP2 microdeletions and microduplications in the etiology of neurodevelopmental disorders

  2016cites this paper
• Human iPSC-derived neurons and lymphoblastoid cells for personalized medicine research in neuropsychiatric disorders

  2016cites this paper